Anna Pagonakis

Array ( [id] => 9245407 [patent_doc_number] => 08609688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Substituted imidazopyridinyl-aminopyridine compounds' [patent_app_type] => utility [patent_app_number] => 13/529459 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57497 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13529459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721346 [patent_doc_number] => 20130072563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'PERACID AND 2-HYDROXY ORGANIC ACID COMPOSITIONS AND METHODS FOR SANITATION AND DISEASE PREVENTION' [patent_app_type] => utility [patent_app_number] => 13/528724 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19103 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733840 [patent_doc_number] => 20130079408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'PERACID AND 2-HYDROXY ORGANIC ACID COMPOSITIONS AND METHODS FOR TREATING ITEMS' [patent_app_type] => utility [patent_app_number] => 13/528734 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18206 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515890 [patent_doc_number] => 20120315298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'LOCAL TREATMENT OF NEUROFIBROMAS' [patent_app_type] => utility [patent_app_number] => 13/524590 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515890 [patent_doc_number] => 20120315298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'LOCAL TREATMENT OF NEUROFIBROMAS' [patent_app_type] => utility [patent_app_number] => 13/524590 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11783946 [patent_doc_number] => 09393219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Monophenols and benzenediols sensitization of immune system against haptenized melanoma antigens' [patent_app_type] => utility [patent_app_number] => 13/493284 [patent_app_country] => US [patent_app_date] => 2012-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7842 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13493284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273631 [patent_doc_number] => 08637563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes' [patent_app_type] => utility [patent_app_number] => 13/487512 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14693 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503171 [patent_doc_number] => 20120302579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'CANCER TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 13/487488 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14248 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510324 [patent_doc_number] => 20120309732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'METHOD FOR INHIBITION OF TUMOR CELL GROWTH USING (22R)-5alpha-LANOSTA-8,24-DIEN-3Beta,15alpha,21-TRIOL' [patent_app_type] => utility [patent_app_number] => 13/483620 [patent_app_country] => US [patent_app_date] => 2012-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4906 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13483620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503112 [patent_doc_number] => 20120302520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'GEMCITABINE COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 13/482940 [patent_app_country] => US [patent_app_date] => 2012-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15020 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13482940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780584 [patent_doc_number] => 20130102559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/477963 [patent_app_country] => US [patent_app_date] => 2012-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18466 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394266 [patent_doc_number] => 20120232107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'NON-PEPTIDE ANTAGONISTS OF GASTRIN RELEASING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/473507 [patent_app_country] => US [patent_app_date] => 2012-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15570 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338359 [patent_doc_number] => 20140065141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'CSF-1R INHIBITORS FOR TREATMENT OF BRAIN TUMORS' [patent_app_type] => utility [patent_app_number] => 14/114878 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 20477 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8744563 [patent_doc_number] => 20130084280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'COMPOSITIONS INCLUDING TRICIRIBINE AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/463576 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 55799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359646 [patent_doc_number] => 20120214813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/461855 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5022 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103802 [patent_doc_number] => 09139576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Aminomethyl biaryl benzotriazole derivatives' [patent_app_type] => utility [patent_app_number] => 14/115123 [patent_app_country] => US [patent_app_date] => 2012-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22151 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11793130 [patent_doc_number] => 09402820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors' [patent_app_type] => utility [patent_app_number] => 14/112906 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 22001 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932737 [patent_doc_number] => 08492437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => '4-substituted phenoxyphenylacetic acid derivatives' [patent_app_type] => utility [patent_app_number] => 13/448689 [patent_app_country] => US [patent_app_date] => 2012-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23040 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1072 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212613 [patent_doc_number] => 20140011790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'METHODS AND MATERIALS FOR REDUCING SUPRESSION OF IMMUNE FUNCTION' [patent_app_type] => utility [patent_app_number] => 14/006536 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4335 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006536 [rel_patent_id] =>[rel_patent_doc_number] =>)